Comparison of ticagrelor and clopidogrel in anemic patients with acute coronary syndrome: efficacy and safety outcomes over one year

被引:0
作者
Tolga Onuk
Fuat Polat
Barış Yaylak
Şükrü Akyüz
Zeynep Kolak
Furkan Durak
机构
[1] Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Educatıon Research Hospıtal,Department of Cardiology
[2] Okan University Faculty of Health Sciences,Department of Cardiology
[3] Prof. Dr. İlhan Varank Sancaktepe Training and Research Hospital,Department of Cardiology
来源
European Journal of Clinical Pharmacology | 2024年 / 80卷
关键词
Ticagrelor; Clopidogrel; Anemia; Acute coronary syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:759 / 770
页数:11
相关论文
共 101 条
  • [1] Sarnak MJ(2002)Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (ARIC) study J Am Coll Cardiol 40 27-33
  • [2] Tighiouart H(2018)Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: insights from the RENAMI registry Thromb Res 167 142-148
  • [3] Manjunath G(2009)Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 1045-1057
  • [4] MacLeod B(2021)Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor Catheter Cardiovasc Interv 98 1309-1316
  • [5] Griffith J(2020)Comparison between Ticagrelor and Clopidogrel in Elderly patients with an Acute Coronary Syndrome: insights from the SWEDEHEART Registry Circulation 142 1700-1708
  • [6] Salem D(2005)Association of hemoglobin levels with clinical out- comes in acute coronary syndromes Circulation 111 2042-2049
  • [7] Levey AS(2010)Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes Eur Heart J 31 50-58
  • [8] Guerrero C(2017)Derivation and valida- tion of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials Lancet 389 1025-1034
  • [9] Garay A(2021)De-escalation of dual antiplatelet therapy in patients with acute coronary syndromes J Am Coll Cardiol 78 763-777
  • [10] Ariza-Solé A(2017)Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study Eur Heart J 38 3070-3078